Table 1.
First author (year) | Study location | Sample size | Data source | Reporting period (2019 & 2020) | Outcomes examined | Risk of bias |
---|---|---|---|---|---|---|
Amram, 202118 | USA | 83,200 | Multi-institutional | Apr-Dec | Screening | Low |
Barriga, 202119 | Chile | 156 | Single-institution | Apr-Jul | Diagnosis | Moderate |
Bessa, 202120 | Brazil | 2,848,181 | Registry | Jan-Dec | Screening | Moderate |
Borsky, 202121 | UK | 238 | Single-institution | Aug-Oct | Diagnosis | Moderate |
Chang, 202122 | USA | 1069 | Multi-institutional | Mar-May | Diagnosis | Moderate |
Chou, 202125 | Taiwan | 243 | Single-institution | Jan-Jul | Diagnosis | Low |
de Degani, 202126 | Argentina | 12,016 | Multi-institutional | Mar-Sep | Screening | Moderate |
DeGroff, 202127 | USA | 75,610 | Multi-institutional | Apr-Jun* | Screening | Moderate |
Eijkelboom, 20219,28 | Netherlands | 9430 | Registry | Week 9-35 | Diagnosis | Low |
Ferrara, 202129 | Italy | 1003 | Multi-institutional | Week 11-20** | Diagnosis | Moderate |
Hamilton, 202130 | UK | 1444 | Multi-institutional | Mar-Sep | Diagnosis | Moderate |
Kaltofen, 202131 | Germany | 320 | Single-institution | Jan-Jun | Diagnosis | Moderate |
Kang, 202132 | South Korea | 35,943 | Multi-institutional | Feb-Jul | Both | Moderate |
Kempf, 202133 | France | 1145 | Single-institution | Mar-Sep | Diagnosis | Moderate |
Knoll, 202134 | Austria | 475 | Single-institution | Mar-Dec | Diagnosis | Low |
Lloyd, 202135 | USA | 11,011 | Single-institution | Jan-Dec*** | Both | Moderate |
Mantellini, 202010 | Italy | 1,283,703 | Registry | Jan-May | Screening | Moderate |
Miller, 202136 | USA | 29,180 | Single-institution | Mar-Oct | Screening | Low |
Morais, 202137 | Portugal | 597 | Single-institution | Mar-Jul | Diagnosis | Moderate |
O’Brien, 202138 | UK | 396 | Single-institution | Feb-Jul | Diagnosis | Moderate |
Sacoto, 202139 | Spain | 21,775 | Single-institution | Jan-Dec | Both | Moderate |
Skovlund, 202140 | Denmark | 823 | Registry | Feb-May* | Diagnosis | Moderate |
Sprague, 202141 | USA | 316,494 | Multi-institutional | Jan-Jul | Screening | Moderate |
Tonneson, 202142 | USA | 571 | Single-institution | Mar-Aug | Diagnosis | Moderate |
Toss, 202143 | Italy | 25,389 | Single-institution | May-Jul | Both | Moderate |
Tsai, 202044 | Taiwan | 704,834 | Registry | Jan-Apr | Screening | Low |
Tsibulak, 202045,46 | Austria | 552 | Multi-institutional | Mar-May | Diagnosis | Moderate |
van Wyk, 202147 | South Africa | 386 | Single-institution | Apr-Jun | Diagnosis | Moderate |
Vardhanabhuti, 202148 | Hong Kong | 8092 | Registry | Jan-Dec | Diagnosis | Moderate |
Velazquez, 202149 | USA | 9047 | Single-institution | Jan-Dec | Screening | Low |
Vrdoljak, 202150 | Croatia | 5723 | Registry | Jan-Dec | Diagnosis | Moderate |
*Pre-COVID period included 2015-2019 [average].
**Pre-COVID period included 2018-2019 [average].
***Pre-COVID period included 2016-2019 [average].